These systems utilize a range of proprietary reagents meticulously designed to boost the production of recombinant antibodies in 293 and CHO cells. Sino Biological offers diverse packages tailored ...

Figure 6: Phagocytosis of LT-scFv-modified Jurkat cells by monocytes. To establish whether molecules other than scFv antibody fragments could be lipid-modified and inserted into cell membranes ...

Expressing recombinant antibodies in mammalian cells is essential when post-translational alterations and proper folding are required for downstream applications. The most common problems of ...

Invivyd (IVVD) announces that The New England Journal of Medicine, NEJM, has published a peer-reviewed Letter to the Editor describing the ...

Memo Therapeutics (MTx) has completed patient enrolment for its US-based Phase II clinical trial of potravitug, a monoclonal ...

where a targeted antibody is attached to a powerful medicine, allowing for a precise attack on cancer cells or other diseased ...

Huonslab is also developing HLB3-002, a stand-alone rHuPH20 drug product under the brand name of Hydizyme™ in the ...

Cells are used as an expression host by most biopharma companies to synthesise recombinant monoclonal antibodies and proteins. The market is expected to grow in the upcoming years due to the ...